Arkema SA Ownership
| ARKAF Stock | USD 88.66 1.43 1.59% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Arkema |
Arkema Pink Sheet Ownership Analysis
About 51.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Arkema SA has Price/Earnings To Growth (PEG) ratio of 0.75. The entity recorded earning per share (EPS) of 15.21. The firm last dividend was issued on the 23rd of May 2022. Arkema SA had 1036:1000 split on the 20th of November 2014. Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.The quote for Arkema SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Arkema SA please contact Thierry Henaff at 33 1 49 00 74 63 or go to https://www.arkema.com.Currently Active Assets on Macroaxis
Other Information on Investing in Arkema Pink Sheet
Arkema SA financial ratios help investors to determine whether Arkema Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arkema with respect to the benefits of owning Arkema SA security.